Fig. 5: NPC risk signature exhibits a strong power for prognosis assessment. | British Journal of Cancer

Fig. 5: NPC risk signature exhibits a strong power for prognosis assessment.

From: Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma

Fig. 5

a ROC curve showing the predictive value of NPC risk signature for 1-, 3-, and 5-year survival rates. b Comparison of predictive value between NPC risk signature and clinicopathologic features. Univariate Cox (c) and multivariate Cox analyses (d) evaluating the independent prognostic value of the NPC risk signature in terms of DFS.

Back to article page